Cefprozil
![]() | |
Clinical data | |
---|---|
Trade names | Cefzil, Cefproz, others |
Other names | Cefproxil |
AHFS/Drugs.com | Monograph |
MedlinePlus | a698022 |
License data |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 95% |
Protein binding | 36% |
Elimination half-life | 1.3 hours |
Identifiers | |
| |
JSmol) | |
| |
| |
![]() ![]() |
Cefprozil is a second-generation cephalosporin antibiotic.[1] Originally discovered in 1983, and approved in 1992,[2] it was sold under the tradename Cefzil by Bristol Meyers Squibb until 2010 when the brand name version was discontinued.[3] It continues to be available from various companies in its generic form.[4] It is used in the treatment of pharyngitis, tonsillitis, ear infections, acute sinusitis, bacterial exacerbation of chronic bronchitis, and skin and skin structure infections.[5] It is currently available as a tablet and as a liquid suspension.
Adverse effects
Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, research has shown no increased risk for cross-allergy for cefprozil and several other second-generation or later cephalosporins.[6] The most common side effects were increased hepatic lab values (including AST and ALGT), dizziness, eosinophilia, diaper rash and superinfection, genital pruritus, vaginitis, diarrhea, nausea, vomiting, and abdominal pain.[5]
Spectrum of bacterial susceptibility and resistance
Currently, bacteria like
Synthesis
This is not a direct copy of Lednicer book like at first glance, but is sourced from the primary reference material.
![](http://upload.wikimedia.org/wikipedia/commons/thumb/8/8b/Cefprozil_synthesis.svg/500px-Cefprozil_synthesis.svg.png)
Displacement of the allylic chloride in intermediate (1) with triphenylphosphine gives the phosphonium salt (2). This functionality is then converted to its ylide; condensation with acetaldehyde then leads to the vinyl derivative (3); deprotection then gives cefprozil. Semisynthetic oral cephalosporin consisting of ~90:10 Z/E isomeric mixture.[12][13]
References
- ^ "Cefzil (cefprozil) dosing, indications, interactions, adverse effects, and more". reference.medscape.com. Retrieved 2021-05-12.
- ISBN 9783527607495.
- National Archives. 11 September 2018.
- ^ "Drugs@FDA: FDA-Approved Drugs". www.accessdata.fda.gov. Retrieved 2022-08-03.
- ^ a b "Cefzil® (CEFPROZIL) Prescribing Facts" (PDF). U.S. Food and Drug Administration. Bristol Myers Squibb.
- PMID 16451776. Archived from the originalon 2012-09-16. Retrieved 2011-02-26.
- ^ "Cefprozil Susceptibility and Resistance Data" (PDF). Retrieved 23 July 2013.
- Bristol-Myers
- Bristol-Myers
- PMID 3624077.
- Bristol-Myers
- PMID 3500158.
- PMID 1080338.
External links
- Cefprozil MedlinePlus Drug Information